These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
304 related articles for article (PubMed ID: 33500715)
1. CYP1A2 suppresses hepatocellular carcinoma through antagonizing HGF/MET signaling. Yu J; Xia X; Dong Y; Gong Z; Li G; Chen GG; Lai PBS Theranostics; 2021; 11(5):2123-2136. PubMed ID: 33500715 [No Abstract] [Full Text] [Related]
2. MicroRNA-101-3p suppresses proliferation and migration in hepatocellular carcinoma by targeting the HGF/c-Met pathway. Liu Y; Tan J; Ou S; Chen J; Chen L Invest New Drugs; 2020 Feb; 38(1):60-69. PubMed ID: 30929159 [TBL] [Abstract][Full Text] [Related]
3. LINC00240 sponges miR-4465 to promote proliferation, migration, and invasion of hepatocellular carcinoma cells via HGF/c-MET signaling pathway. Bu WJ; Fang Z; Li WL; Wang X; Dong MJ; Tao QY; Zhang L; Xu YQ Eur Rev Med Pharmacol Sci; 2020 Oct; 24(20):10452-10461. PubMed ID: 33155201 [TBL] [Abstract][Full Text] [Related]
4. Chinese herbal formula QHF inhibits hepatocellular carcinoma metastasis via HGF/c-Met signaling pathway. Yuan S; Gong Y; Chen R; Du J; Zhang H; Chen T Biomed Pharmacother; 2020 Dec; 132():110867. PubMed ID: 33075668 [TBL] [Abstract][Full Text] [Related]
5. Attenuation of MET-mediated migration and invasion in hepatocellular carcinoma cells by SOCS1. Gui Y; Khan MGM; Bobbala D; Dubois C; Ramanathan S; Saucier C; Ilangumaran S World J Gastroenterol; 2017 Sep; 23(36):6639-6649. PubMed ID: 29085209 [TBL] [Abstract][Full Text] [Related]
6. MACC1 suppresses cell apoptosis in hepatocellular carcinoma by targeting the HGF/c-MET/AKT pathway. Yao Y; Dou C; Lu Z; Zheng X; Liu Q Cell Physiol Biochem; 2015; 35(3):983-96. PubMed ID: 25660117 [TBL] [Abstract][Full Text] [Related]
7. Cooperative interaction of MUC1 with the HGF/c-Met pathway during hepatocarcinogenesis. Bozkaya G; Korhan P; Cokaklı M; Erdal E; Sağol O; Karademir S; Korch C; Atabey N Mol Cancer; 2012 Sep; 11():64. PubMed ID: 22962849 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-449a suppresses hepatocellular carcinoma cell growth via G1 phase arrest and the HGF/MET c-Met pathway. Cheng J; Wu LM; Deng XS; Wu J; Lv Z; Zhao HF; Yang Z; Ni Y Hepatobiliary Pancreat Dis Int; 2018 Aug; 17(4):336-344. PubMed ID: 30108016 [TBL] [Abstract][Full Text] [Related]
9. Resveratrol suppresses human hepatocellular carcinoma via targeting HGF-c-Met signaling pathway. Gao F; Deng G; Liu W; Zhou K; Li M Oncol Rep; 2017 Feb; 37(2):1203-1211. PubMed ID: 28075467 [TBL] [Abstract][Full Text] [Related]
10. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. Tan S; Li R; Ding K; Lobie PE; Zhu T FEBS Lett; 2011 Jul; 585(14):2229-34. PubMed ID: 21658389 [TBL] [Abstract][Full Text] [Related]
11. MicroRNA-26a suppresses angiogenesis in human hepatocellular carcinoma by targeting hepatocyte growth factor-cMet pathway. Yang X; Zhang XF; Lu X; Jia HL; Liang L; Dong QZ; Ye QH; Qin LX Hepatology; 2014 May; 59(5):1874-85. PubMed ID: 24259426 [TBL] [Abstract][Full Text] [Related]
12. u-PA and c-MET mRNA expression is co-ordinately enhanced while hepatocyte growth factor mRNA is down-regulated in human hepatocellular carcinoma. Tavian D; De Petro G; Benetti A; Portolani N; Giulini SM; Barlati S Int J Cancer; 2000 Sep; 87(5):644-9. PubMed ID: 10925356 [TBL] [Abstract][Full Text] [Related]
13. Deubiquitinating enzyme USP46 suppresses the progression of hepatocellular carcinoma by stabilizing MST1. Qiu Y; Huang D; Sheng Y; Huang J; Li N; Zhang S; Hong Z; Yin X; Yan J Exp Cell Res; 2021 Aug; 405(1):112646. PubMed ID: 34029571 [TBL] [Abstract][Full Text] [Related]
14. SIX4 promotes hepatocellular carcinoma metastasis through upregulating YAP1 and c-MET. He Q; Lin Z; Wang Z; Huang W; Tian D; Liu M; Xia L Oncogene; 2020 Dec; 39(50):7279-7295. PubMed ID: 33046796 [TBL] [Abstract][Full Text] [Related]
15. C7 peptide inhibits hepatocellular carcinoma metastasis by targeting the HGF/c-Met signaling pathway. Zhao M; Wang Y; Liu Y; Zhang W; Liu Y; Yang X; Cao Y; Wang S Cancer Biol Ther; 2019; 20(12):1430-1442. PubMed ID: 31441380 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-424-5p acts as a potential biomarker and inhibits proliferation and invasion in hepatocellular carcinoma by targeting TRIM29. Du H; Xu Q; Xiao S; Wu Z; Gong J; Liu C; Ren G; Wu H Life Sci; 2019 May; 224():1-11. PubMed ID: 30876939 [TBL] [Abstract][Full Text] [Related]
17. Anticancer and Antiangiogenic Activities of Novel α-Mangostin Glycosides in Human Hepatocellular Carcinoma Cells via Downregulation of c-Met and HIF-1α. Kim SM; Han JM; Le TT; Sohng JK; Jung HJ Int J Mol Sci; 2020 Jun; 21(11):. PubMed ID: 32516967 [TBL] [Abstract][Full Text] [Related]
18. The EGFR/ErbB3 Pathway Acts as a Compensatory Survival Mechanism upon c-Met Inhibition in Human c-Met+ Hepatocellular Carcinoma. Steinway SN; Dang H; You H; Rountree CB; Ding W PLoS One; 2015; 10(5):e0128159. PubMed ID: 26000702 [TBL] [Abstract][Full Text] [Related]
19. C1GALT1 enhances proliferation of hepatocellular carcinoma cells via modulating MET glycosylation and dimerization. Wu YM; Liu CH; Huang MJ; Lai HS; Lee PH; Hu RH; Huang MC Cancer Res; 2013 Sep; 73(17):5580-90. PubMed ID: 23832667 [TBL] [Abstract][Full Text] [Related]
20. Heparin inhibits Hepatocyte Growth Factor induced motility and invasion of hepatocellular carcinoma cells through early growth response protein 1. Ozen E; Gozukizil A; Erdal E; Uren A; Bottaro DP; Atabey N PLoS One; 2012; 7(8):e42717. PubMed ID: 22912725 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]